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The heart of a newborn mouse has an exceptional capacity to regenerate from
myocardial injury that is lost within the first week of its life. In order to elucidate
the molecular mechanisms taking place in the mouse heart during this critical period
we applied an untargeted combinatory multiomics approach using large-scale mass
spectrometry-based quantitative proteomics, metabolomics and mRNA sequencing on
hearts from 1-day-old and 7-day-old mice. As a result, we quantified 1.937 proteins (366
differentially expressed), 612 metabolites (263 differentially regulated) and revealed 2.586
differentially expressed gene loci (2.175 annotated genes). The analyses pinpointed
the fructose-induced glycolysis-pathway to be markedly active in 1-day-old neonatal
mice. Integrated analysis of the data convincingly demonstrated cardiac metabolic
reprogramming from glycolysis to oxidative phosphorylation in 7-days old mice, with
increases of key enzymes and metabolites in fatty acid transport (acylcarnitines) and
β-oxidation. An upsurge in the formation of reactive oxygen species and an increase in
oxidative stress markers, e.g., lipid peroxidation, altered sphingolipid and plasmalogen
metabolism were also evident in 7-days mice. In vitro maintenance of physiological fetal
hypoxic conditions retained the proliferative capacity of cardiomyocytes isolated from
newborn mice hearts. In summary, we provide here a holistic, multiomics view toward
early postnatal changes associated with loss of a tissue regenerative capacity in the
neonatal mouse heart. These results may provide insight into mechanisms of human
cardiac diseases associated with tissue regenerative incapacity at the molecular level,
and offer a prospect to discovery of novel therapeutic targets.
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INTRODUCTION
In the early postnatal days the mammalian heart needs to
adapt to an increased workload and energy demand under
increased blood oxygen levels (Patterson and Zhang, 2010).
The heart cells rely on oxidative phosphorylation and versatile
energy substrate dynamics, such as beta-oxidation of fatty acids,
oxidation of lactate to pyruvate, and to a moderate extent glucose
utilization, for production of adequate amounts of energy to
compensate for the increased requirements. During the first week
of postnatal heart development, major adaptive physiological
transitions take place due to changes in oxygen pressure,
workload and availability of substrates for energy metabolism,
which induces a shift from glycolytic energy production to
oxidative phosphorylation, as well as mitochondrial biogenesis
and remodeling (Lopaschuk et al., 1994; Neary et al., 2014;
Puente et al., 2014). The increase in postnatal environmental
oxygen supply, with the subsequent up-regulation of oxidative
metabolism, as well as a rise in production of mitochondrial
reactive oxygen species (ROS), triggers cardiomyocytes to exit
the cell-cycle shortly after birth (Puente et al., 2014; Nakada
et al., 2017). The block of cytokinesis evokes binucleation of the
cardiomyocytes, with the consequent loss of their proliferative
capacity leading to terminal differentiation at 7 days postnatal
(Soonpaa et al., 1996; Leu et al., 2001; Porrello and Olson, 2014).
Subsequent heart growth is achieved through an increase in cell
size, i.e., hypertrophy. The shift from fetal to adult metabolism
during the first postpartum week has gained attention due to
the observed loss of the heart’s regenerative capacity at day 7
and after through adulthood (Porrello and Olson, 2014; Uygur
and Lee, 2016; Vivien et al., 2016). An ischemic insult and
myocardial infarction, for example, readily cause the death
of billions of cardiomyocytes with substantial damage to the
left ventricle and subsequent fibrotic scar formation, eventually
leading to fatal arrhythmias and heart failure (Xin et al., 2013).
In contrast to adult hearts, the newborn mouse heart possesses
an intriguing inherent capacity to regenerate upon myocardial
injury (Porrello and Olson, 2014; Uygur and Lee, 2016; Vivien
et al., 2016). Elucidating the mechanisms associated with the
immense repair potential and regenerative capacity early after
birth can contribute to discovery of novel therapeutic targets
for cardiac diseases causing cardiomyocyte loss and fibrosis that
are significant contributors to cardiovascular mortality (Lerman
et al., 2016).
The plausible basis of the ineffective cardiac regeneration
in mammals is the low proliferative capacity of adult
cardiomyocytes (Foglia and Poss, 2016). Since cardiomyocytes
cannot undergo self-renewal, differentiation and repair,
myocardial injury and cardiomyocyte loss remain untreatable,
and novel strategies to increase cardiomyocyte renewal are
explored (Sahara et al., 2015). In addition to neonatal mice,
which are capable to regenerate their myocardial damage
provoked by apical resection (Porrello et al., 2011) or left
anterior descending artery ligation (Haubner et al., 2012)
within 3 weeks, cardiomyocytes in the hearts of some vertebrate
animal models e.g., newts and zebrafish (Poss et al., 2002;
Witman et al., 2011) can de-differentiate in order to promote
cardiomyocyte proliferation to compensate for lost cells after
a myocardial infarction (MI). Furthermore, functional cardiac
recovery of a human neonatal heart upon MI has been reported
(Haubner et al., 2016). Further studies using neonatal mice
as the model of cardiac regeneration have revealed that the
new cardiomyocytes were generated from de-differentiation
and proliferation of pre-existing mature cardiomyocytes
(Jopling et al., 2010; Haubner et al., 2012; Mollova et al., 2013;
Porrello et al., 2013; Senyo et al., 2013). The de-differentiated
cardiomyocytes expressed markers characteristic of immature
cardiomyocytes, had disassembled sarcomere structures and
possessed an increased propensity for cell-cycle entry and
thus proliferation (Jopling et al., 2010; Porrello et al., 2011),
indicative of a connection between the cardiomyocyte contractile
apparatus and the cell-cycle machinery (Vivien et al., 2016).
However, the precise mechanisms underlying the regenerative
capacity of the neonatal mouse model are only partially
understood (Porrello et al., 2011; Haubner et al., 2012). Studies
manipulating the cardiomyocyte genetic program or signaling
environment to awaken innate regenerative programs have
revealed that modulation of Neuregulin 1/v-erb-b2 avian
erythroblastic leukemia viral oncogene homolog 4, NRG1-
ERbB4 signaling (Bersell et al., 2009), Hippo-Yes associated
protein, Hippo-YAP signaling (Heallen et al., 2013), cardiac
innervation (Mahmoud et al., 2015; White et al., 2015), hypoxia
and ROS (Puente et al., 2014), inflammatory response (Aurora
et al., 2014) and miRNAs (Eulalio et al., 2012) play a key role
in the regulation of cardiomyocyte proliferation and heart
regeneration.
It is therefore clear that the regenerative capacity of the
neonatal mouse model can be utilized as a valuable tool to
elucidate the processes related to heart regeneration and to
devise strategies that may be of potential value for treatment
of human cardiac diseases. Since changes in energy metabolism
are the central elements in the regenerative capacity (Eming
et al., 2017; Nakada et al., 2017), and instead of focusing
on single entities, we adapted a systems biology approach to
generate in-depth knowledge of the transcriptomic, proteomic
and metabolomic changes that occur at the tissue level in
the extensively studied neonatal mouse heart model. The
metabolomic profile of a tissue is a good representation of
the final response to both autocrine and paracrine signaling,
and combining proteomics and metabolomics to quantify
changes in metabolites and their corresponding enzymes offers a
complementary read-out for data interpretation that can advance
our understanding of the mechanisms of regeneration (Mayr
et al., 2007). In this work, we have demonstrated the differential
regulation of 263 metabolites as well as mapped 366 proteins
and 2,175 genes whose expression is differentially regulated
during neonatal heart development. We linked these changes to
metabolic reprogramming in the neonatal mouse heart during
the first week of life. Moreover, we characterized in detail
several cellular pathways and processes underlying neonatal
heart development and regeneration, and pinpointed the
fructolytic pathway to be predominant and functionally linked
to increased cardiomyocyte proliferation in 1-day-old neonatal
mice.
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MATERIALS AND METHODS
Animals
All animal experiments were made according to the European
Community guidelines for use of experimental animals and
approved by the Finnish National Animal Experiment Board
(permission number ESAVI/6718/04.10.03/2012). Hearts of
postnatal day 1 (P1) and day 7 (P7) Hsd:ICR(CD-1 R©) male mice
were harvested. The atrial appendages were removed, hearts were
flash frozen in liquid nitrogen and stored until processing at
−80◦C.
Sex Determination of Neonatal Mice Using
qRT-PCR
A qRT-PCR assay that exhibits specificity for the sex-determining
region of the Y chromosome was designed using a set of
primers specific to the murine Sry gene (GenBank NM_011564.1
sequence). Isolation of genomic gDNA from mouse livers
of the same animals was done with a Genomic DNA from
tissue kit (Macherey-Nagel, Düren, Germany). Quantitative
real-time reverse transcription (RT)-PCR was performed using
LightCycler R© 480 SYBR Green I Master Mix (Roche) with 50
ng of template gDNA according to manufacturer’s instructions.
gDNA from an adult male and female mouse served as controls.
Whole Transcriptomic Analysis by RNA-seq
The hearts were snap frozen in liquid nitrogen and processed
with the Precellys R© 24 homogenizer with ceramic beads (Bertin
Technologies). RNA from four P1 and four P7 mouse hearts
was isolated with TRIzol as described (Rio et al., 2010),
followed by DNAse I treatment. Agilent Bioanalyzer RNA pico
chip (Agilent) was used to evaluate the integrity of RNA
and Qubit RNA-kit (Life Technologies) to quantitate RNA.
From each sample, a 1.5 µg of total RNA was collected,
ribodepleted and further prepared to RNA-seq library by
using ScriptSeq v2TM Complete kit (Illumina, Inc., San Diego,
CA, USA). RNA-seq libraries were purified with SPRI beads
(Agencourt AMPure XP, Beckman Coulter, Brea, CA, USA).
The library QC was evaluated on High Sensitivity chips by
Agilent Bioanalyzer (Agilent). Paired-end sequencing of RNA-
seq libraries was done on an Illumina HiSeq platform (HiSeq
2000, Illumina, Inc., San Diego, CA, USA) using 100 cycles
in each direction. The bioinformatic analysis of RNA-seq data
was carried out by Exiqon A/S (Vedbaek, Denmark; currently
Qiagen, http://www.exiqon.com) and included alignment of
reads to the mouse reference genome (GRCm38; annotation
reference: Ensembl_70), feature summation, and normalization
of expression estimates. To allow the comparison of expression
estimates between samples, the normalized expression values
for each transcript were calculated as Fragments per Kilobase
per Million Mapped Reads (FPKM). The expression profile of
P7 heart samples were compared to the profile of P1 hearts;
for each transcript the ratio between the average FPKMs was
calculated and log2 transformed to log2FC-values. Transcripts
showing a |FC| ≥1.5 and a False Discovery Rate (FDR)
<0.05 were classified as differentially expressed. The list of
all identified transcripts, indicating the differentially expressed
genes (DEG) is provided in Tables S6C,D. The data were
submitted to NCBI Gene Expression Omnibus (GEO) and are
available under the accession number GSE107760 (release date
01.12.2018).
Validation of Fructolytic Pathway With
Quantitative PCR
For quantitative PCR analyses, the RNA was isolated with
TRIzol as described above, and reverse-transcribed using Bioline
SensiFAST cDNA synthesis kit according to the manufacturer’s
instructions. Primer sequences of qPCR primers were as
follows: Slc2a1(Glut1), 5′-CAGTTCGGCTATAACACTGGTG-
3′ and 5′-GCCCCCGACAGAGAAGAT-3′, Khk-c, 5′-GCGTGG
ATGTGTCTCAGGTG-3′ and 5′-TGTTGACGATGCAGCAAG
A-3′; Slc16a3 (Mct4), 5′-GCCACCTCAACGCCTGCTA-3′ and
5′-TGTCGGGTACACCCATATCCTTA-3′; Pfkfb2, 5′-CGGGA
ATGGATCTACACTGG-3′ and 5′-GGAGAGCAAAGTGAGG
GATG-3′, 18S 5′-ACATCCAAGGAAGGCAGCAG-3′ and 5′-
TTTTCGTCACTACCTCCCCG-3′. Quantitative real-time PCR
reactions were prepared with Roche FastStart Essential DNA
GreenMaster as recommended by themanufacturer and run on a
LightCycler 96 instrument (Roche). Ct-values were normalized to
the housekeeping gene 18S. Relative gene expression values were
calculated as described (Livak and Schmittgen, 2001).
Proteomic Analyses
Sample Preparation and Proteolytic Digestion
Individual frozen hearts of 1 day old male mice (n = 6) and 7
day old male mice (n = 6) were homogenized for 25 s at 4◦C
in 7M urea, 2M thiourea, 4% CHAPS using a Precellys R© 24
homogenizer (Bertin Technologies). Samples were centrifuged
for 1min at 16.000 g. Ten micrograms of total protein lysate
amounts were taken to be processed for digestion, usingmodified
FASP protocol as previously described (Scifo et al., 2015).
Quantitative Liquid Chromatography Tandem Mass
Spectrometry HDMSE
For HDMSE analysis, 300 ng of digested proteins/replicate (3
replicate runs per sample) was injected into the column and
processed as described in Laakkonen et al. (2017).
Database Mining, Quantification and Statistical
Analysis
Relative quantification between samples using precursor
ion intensities was performed with Progenesis QI for
ProteomicsTM Informatics for Proteomics software (Non-
linear Dynamics/Waters) and ProteinLynx Global Server
(PLGS v3.0) (Laakkonen et al., 2017). Database searches were
carried out against Mus musculus UniProtKB-database (release
2014_11, 33214 entries) with Ion Accounting algorithm using
the following parameters: peptide and fragment tolerance:
automatic, maximum protein mass: 500 kDa, min fragment
ions matches per protein ≥7, min fragment ions matches per
peptide ≥3, min peptide matches per protein ≥1, primary digest
reagent: trypsin, missed cleavages allowed: 2, fixed modification:
carbamidomethylation C, variable modifications: deamidation
of asparagine and glutamine (NQ) residues, oxidation of
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methionine (M) and FDR < 4%. All of the identifications
were subsequently refined to only Mus musculus identifiers,
and protein lists were simplified by protein grouping. Protein
quantitation was performed entirely on non-conflicting features,
using precursor ion intensity data and standardized expression
profiles. The stringency of accepted protein leads was increased
by limiting the ratio between P7 as compared to P1 (differentially
expressed proteins, DEP; fold change, |FC| > 1.5, computed
from averaged, normalized protein intensities, and p < 0.05
by ANOVA for all comparisons, two unique peptides for
quantitation).
Protein Bioinformatics Analyses
The lists of up/down regulated protein changes with their
corresponding, unique UniProtKB-database identifiers served
as inputs into Ingenuity Pathways (IPA, Ingenuity systems,
Redwood City, CA; www.ingenuity.com), with a main focus
on Canonical pathways, and Disease and Function annotation.
The Benjamini-Hochberg (B-H) multiple correction test
was used to correct the p-values. Only most meaningful
functional annotations, showing the lowest FDR were evaluated,
furthermore, only z-scores ≥+2 (predicted activation) or ≤-2
(predicted inhibition) were considered (Pezzini et al., 2017). The
functional annotation of terms was performed with ClueGO
(v. 2.3.2; Bindea et al., 2009), utilizing as input DEP and
KEGG/Reactome Pathway and Gene Ontology biological process
annotation, and kappa score threshold of 0.4. The parameters
relevant to the ClueGO analysis are reported in Table S2. The
scatter and hierarchical clustering plots were drawn with Orange
software (v.3.3; Demsar et al., 2013), while functional networks
were drawn with Cytoscape (v.3.3; Shannon et al., 2003). The
mitochondrial assignments were performed as described before
(Mäkelä et al., 2016; Tikka et al., 2016), by utilizingmitochondrial
annotations from IMPI database (http://www.mrc-mbu.cam.ac.
uk/impi).
Global Metabolomic Analysis
Sample Preparation
P1 and P7 male mouse hearts were represented by four samples
each, where each sample was a pool of four hearts (due
to minimal tissue requirements of Metabolon, Inc.). Mouse
hearts were shipped to Metabolon, Inc. (Durham, NC) and
following receipt, samples were immediately stored at −80◦C.
Sample preparation was carried out as described previously at
Metabolon, Inc. (Evans et al., 2009).
Non-targeted Global Metabolomic Mass
Spectrometry Analysis
Non-targeted global metabolomic MS analysis was performed
at Metabolon, Inc. Extracts were subjected to a UPLC-MS/MS
platform, which utilized a Waters Acquity UPLC with Waters
UPLC BEH C18-2.1 × 100mm, 1.7µm column and Q-Exactive
high resolution/accurate mass spectrometer (Thermo Scientific),
interfaced with a heated electrospray ionization (HESI-II) source
and Orbitrap mass analyser operated at 35,000 mass resolution,
and processed as described in Evans et al. (2014).
Compound Identification, Quantification, Data
Curation and Statistical Analysis
Metabolites were identified by automated comparison of the ion
features in the experimental samples to a reference library of
chemical standard entries that included retention time,molecular
weight (m/z), preferred adducts, and in-source fragments as
well as associated MS spectra and curated by visual inspection
for quality control using software developed at Metabolon as
described (DeHaven et al., 2010). Welch’s two-sample t-test was
used to identify molecules that differed significantly between
experimental groups (p ≤ 0.05).
Transmission Electron Microscopy
Cardiac samples (∼1mm2) for transmission electronmicroscopy
were harvested from the left ventricular wall, fixed in 2,5% EM
grade glutaraldehyde in 100mM sodium-phosphate buffer for
2 h followed by a 24 h stabilization in fresh 100mM sodium-
phosphate buffer (4◦C). Then, samples were post-fixed with
1% osmium tetroxide (1 h, RT), dehydrated with graded series
of ethanol followed by acetone treatment and embedding in
resin. Thin-sectioned samples were viewed and photographed
with a Jeol JEM-1400 transmission electron microscope (Jeol
Ltd., Tokyo, Japan). Mitochondrial number, volume fraction
and trans-sectional area were analyzed with ImageJ software
(v1.47, National Institute of Health, MD; Schneider et al., 2012).
For the number of cristae per µm, the ImageJ line tool was
used to draw a line across the stack of cristae, perpendicular
to their orientation. The number of cristae crossing the line
was counted and expressed in relation to the line length
(Puente et al., 2014).
High-Resolution Respirometry With
Oxygraph-2k
The mitochondrial respiration in the tissue was analyzed using
the Oxygraph-2k (OROBOROS Instruments Corp., Innsbruck,
Austria). Male mice hearts were excised as described above,
and samples were prepared according to the manufacturer’s
Oxygraph-2k respirometer instructions. Briefly, 5mg of tissue
was homogenized in a SG3 shredder (Pressure Biosciences Inc.,
MA) at−20◦C for 10 s (setting 1) and 5 s (setting 2) in 500µl ice-
cold MiRO6 buffer (0.5mM EGTA, 3mM MgCl2·6H2O, 60mM
K-lactobionate, 20mM taurine, 10mMKH2PO4, 20mMHEPES,
110mM sucrose, 1 g/l BSA, 280 u/ml catalase, pH 7.1). The
contents were then further diluted with 4.5ml MiRO6 buffer,
of which 2.5ml was transferred to each of the two chambers of
an Oxygraph-2k instrument and allowed to incubate for 20min
before starting the substrate-uncoupler-inhibitor titration (SUIT)
protocol (Pesta and Gnaiger, 2012).
Immunoblotting, Immunocyto- and
Immunohistochemistry
Mice hearts from six biological replicates of male P1 and P7
mice were harvested as described above and homogenized for
20 s at 4◦C in RIPA Lysis and Extraction Buffer (Thermo
Scientific) supplemented with protease inhibitors (Complete
mini, Roche, Mannheim, Germany) using a Precellys R© 24
homogenizer (Bertin Technologies) with ceramic beads. Protein
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content from vortexed and centrifuged samples was determined
with Pierce BCA protein assay kit (Thermo Fisher Scientific,
Monza, Italy). For Western blotting, 15–25 µg of protein lysates
were resolved on BoltTM 4–12% Bis-Tris Plus gels (Invitrogen,
Carlsbad, CA) using SDS-PAGE under denaturing conditions
and then transferred onto nitrocellulose membranes in an
iBlot R© Dry Blotting System (Invitrogen, Carlsberg, CA). The
membranes were incubated 1 h at RT or O/N in blocking
solution (5% bovine serum albumin or non-fat dry milk in
TBS/0.1%Tween20). Incubation with primary antibodies was
performed overnight (4◦C): β-actin- Abcam 8227, GSK-3β-
Cell Signaling Technology 9315, Rac1- Abcam 33186, Cdc42-
Abcam 64533 and RhoA- Abcam 54835, followed by incubation
with HRP conjugated antibodies (BioRad). Chemiluminescent
detection was performed with Pierce ECL2 Western blotting
substrate (ThermoFisher Scientific, Rockford, IL) according to
manufacturer’s instructions. Data were assessed using ImageJ
software (Schneider et al., 2012) and each band normalized to its
own loading control (Gapdh- Abcam 9485). Data were reported
as mean percentages ± s.e.m. from all repeats, where the average
of 1 day old mice was set to 100% and the data for P7 hearts
expressed as percentages in relation to P1.
Proliferative cardiomyocytes were identified from paraffin-
embedded sections of P1 (n = 10) and P7 (n = 7) mice hearts.
Deparaffinized sections were stained with a Ki-67 antibody (SP6)
(1:100, ThermoFisher Scientific, Fremont, CA) and anti-myosin
heavy chain antibody (1:200, Millipore 05-716) for visualization
of proliferative cells and cardiomyocytes, respectively. The
number of Ki-67 and/or MHC positive and the total number
of cells were counted from medium magnification (x400)
immunofluorescent microscopy images with ImageJ software
(Schneider et al., 2012). Statistical analyses were performed using
Mann-WhitneyU-test, considering significant p-values≤ 0.05 as
∗, p-values ≤ 0.01 as ∗∗ and p-values ≤ 0.001 as ∗∗∗.
Hypoxia Experiments
Neonatal mouse cardiomyocytes were isolated at P1. Briefly,
hearts were collected into ice-cold PBS and isolated with neonatal
heart dissociation and isolation kits following the manufacturer’s
instructions (Miltenyi Biotec, Germany). Experiments were
performed with maintenance medium supplemented with
15mM glucose, 25µM fructose, 10% FBS and 5 units of
penicillin and 5 µg of streptomycin per mL. Cells were exposed
to hypoxia (3% of O2, OxyCycler, BioSpherix, NY) for 24 h.
Control cells were cultured in regular 5% CO2 cell incubator
under normal condition. For immunostaining, the cells were
fixed with 10% paraformaldehyde and Ki-67 antibody (clone
SP6) (1:100, ThermoFisher Scientific, Fremont, CA) and anti-
myosin heavy chain antibody (1:200, Millipore 05-716) were
used for visualization of proliferative cells and cardiomyocytes,
respectively. The number of Ki-67 and/or MHC positive and the
total number of cells were counted from medium magnification
(400x) immunofluorescent microscopy images with ImageJ
software (Schneider et al., 2012). Statistical analyses were
performed using Mann-Whitney U-test, considering significant
p-values ≤ 0.05 as ∗, p-values ≤ 0.01 as ∗∗ and p-values ≤ 0.001
as ∗∗∗.
RESULTS
Proteomic Profiling of the Neonatal Mouse
Heart
In order to elucidate the molecular basis of the regenerative
capacity of the neonatal heart, a label free global proteomic
analysis was performed at first. A total of 1,937 proteins in the
neonatal mouse heart was identified and quantified, of which
366 proteins were differentially expressed (>1.5-fold change,
FC; p < 0.05 and ≥2 unique peptides) between 1 (P1) and 7
(P7) day old mice. A complete survey of the identified proteins
is provided in the Table S1, in which DEP were marked. In
subsequent steps we functionally annotated the DEP using Kyoto
Encyclopedia of Genes and Genomes (KEGG) and Reactome
databases (Figure 1A and Table S2), revealing several processes
related to Cardiac muscle contraction, Cardiac hypertrophy,
Oxidative phosphorylation, Fatty acid elongation, Focal adhesion
and mRNA/protein expression/degradation changes that were
statistically enriched and associated with differential expression
changes at P7 stage. The more detailed picture of functional
enrichments is provided in Figure S1 (KEGG/Reactome pathway
associations, bar chart view), Figure S2 (Gene Ontology
Biological process, GO BP) and Table S2. Utilizing Ingenuity
canonical pathways (IPA) classification, we subsequently revealed
that Oxidative phosphorylation, Mitochondrial dysfunction and
Fatty-acid ß-oxidation I were highly upregulated at P7 in
comparison to P1 hearts, as indicated by their logP∼-8 p-values
(Figure 1B and Table S3). Moreover, mTOR signaling, eIF4
signaling and Thrombin signaling were found to be statistically
significantly downregulated in P7 hearts. Disease and functions
IPA annotation (Figure 1C) showed significant upregulation of
multiple pathways associated with cell apoptosis, including Cell
death of tumor cell lines (70 DEP associated), Apoptosis of tumor
cell lines (56 DEP), and Cell death of leukemia cell lines (18
DEP), all with B-H corrected z-scores >2.5 (Table S4). Other
functions predicted to be strongly associated included Synthesis
and metabolism of ROS (24 and 27 associated DEP; see also
Figure S3), Blood pressure (14 associated DEP, B-H z-score
2.484) and Function of cardiovascular system (23 associated
DEP, B-H z-score 2.046). In summary, novel pathways linked
to cardiovascular function with putative connections to cell
proliferation were identified, as well as a switch to an oxidative
state with an increased ROS formation in the developing neonatal
heart.
Validation of Differentially Expressed
Protein Targets Associated With
Cardiovascular Functions
To complement the functional bioinformatics analyses in
the developing heart, we specifically focused on a network
encompassing Function of cardiovascular system and Blood
Pressure. A total of 30 DEP was associated with these
functions, out of which 12 were significantly upregulated
and 18 downregulated (Figure 2A and Table S5). These DEP
were further linked to Canonical Pathways including Cardiac
hypertrophy, Actin cytoskeletal, Cdc42, Cardiac β-adrenergic,
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FIGURE 1 | Clustering and functional analyses of differential proteomic data in the developing mouse heart. (A) Term enrichment analysis of the differentially
expressed proteins by KEGG and Reactome Pathway. The size of pie chart sections proportionally represents the number of terms assigned to each group, with the
(Continued)
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FIGURE 1 | most significant term per group indicated. The number of DEP assigned to each functional group is reported in brackets, (B) Top Ingenuity Canonical
pathways chart of DEP with B-H adjusted p-values, (C) Disease and function IPA bar chart. The statistically enriched associations were sorted according to significant
z-score values (|z| > 2). Functions in (C) related to Oxidative phosphorylation, Mitochondrial dysfunction and Fatty acid β-oxidation I are indicated in green. Function of
Cardiovascular system, Blood pressure and Synthesis and Metabolism of reactive oxygen species categories are highlighted in blue and green, respectively. n = 6.
and Rac and Rho signaling pathways, as well as Cardiomyocyte
differentiation via BMP receptors. In order to validate the
observed changes from mass spectrometry analysis, we
confirmed the expression of some DEP associated with this
network by semi-quantitative immunoblotting on total heart
lysates. We selected two upregulated DEP (Rac1 and Cdc42) and
one downregulated one (Gsk3b; Figure 2A) with connections
to hypertrophy, as well as RhoA (a key player in RhoA
signaling cascade, quantified with one unique peptide) and
Actb (a key driver of actin cytoskeleton dynamics; Table S1).
Immunoblotting with antibodies against Rac1 (Figure 2B)
revealed bands at 21 kDa and 59.8% ± 9.4 increase in the
signal intensity (p < 0.001) in P7 mice hearts. Antibodies
against Cdc42 demonstrated a 130.6% ± 40.2 increase in the
P7 mice hearts (p < 0.01). RhoA was detected at 22 kDa and
band intensity analysis showed a 34.4% ± 6.5 increase in the
P7 mice hearts. Immunoblotting with anti-Gsk3b antibodies
revealed bands at 46 kDa and a band intensity decrease by 18.9%
± 7.1, in the P7 mice hearts. Actb was detected at 41.7 kDa,
and band intensity analysis showed a 42.8% ± 8.3 decrease
in the P7 mice hearts. In summary, the expression changes of
selected proteins was verified and showed a similar direction
with similar significant p-values. Immunohistochemical staining
(Figure 2C) revealed a significant decrease in the expression of a
proliferation marker, Ki-67 (p = 0.0008, Mann-Whitney U-test)
in P7 cardiomyocytes as compared to P1, further supporting the
switch from proliferation to growth by hypertrophy (Soonpaa
et al., 1996; Leu et al., 2001; Porrello and Olson, 2014). Negative
controls (primary antibody omitted) as well as staining of adult
mice hearts showed no Ki-67 staining (data not shown). Taken
together, we validated that cessation of proliferation in neonatal
heart is accompanied by upregulation of RhoA/Rac1/Cdc42
cytoskeletal signaling related to cardiovascular function and
hypertrophic growth.
Results of RNA-seq Profiling in the
Neonatal Mouse Heart Validate the
Proteomic Data
As another validation for the proteomics experiments, we
performed the RNA-seq analyses of P1 and P7 stage whole
hearts from an independent set of mice (Figures S4A,B).
Altogether eight libraries were prepared from four P1 and
P7 samples and subjected to sequencing on the Illumina
platform. The paired-end sequencing of the libraries generated
in total 401.349473 million 101-base-pair reads and allowed
the identification of altogether 6.133 annotated and 46.231
unannotated transcripts (Tables S6A–D), of which 2.175 and 411
were deemed as statistically significantly differentially expressed
(DEG), respectively. The correlation analysis of the expression
and proteomic data in turn revealed 1,680 common entries
present in both datasets (Table S6E). While a majority of
these common entries were unchanged in their expression
between P1 and P7 stages in both experiments, 35 DEP and
DEG showed a similar and 17 a distinct expression change
(marked in red and blue, respectively, Figures S5A,B). Similar
percentages of DEP (15.57%) and (11.66%, DEG) were found
to be unique for each assay type (Figure S5B). Further mining
of the annotated DEG revealed a list of >350 cardiac genes
that were strongly upregulated (z-score > 2) at the P7 stage.
These genes were associated with functions like contractility,
morphogenesis of endothelial tissue, and vasculogenesis (Table
S7) and corroborated well the proteomic findings. For example,
a very strong upregulation of Signaling by Rho family GTPases
(z-score= 4.964) with 43 DEG was observed, providing a further
support for the differential expression of this pathway that was
also seen in the proteomic analysis (Table S7 and Figure S6).
Similarly, Production of Nitric Oxide and ROS was strongly
upregulated (with 35 DEG, z-score= 3.19), further validating the
dysregulation of this pathway at the P7 stage (Table S7).
Global Metabolomic Profiling of the
Neonatal Mouse Heart
A global metabolomic profiling of the mouse hearts was also
used to enlighten the molecular basis of the loss of the
regenerative capacity. Revealed in the analysis was in total
612 metabolites (Table S8). Among these, 263 metabolites with
perturbed abundance (p ≤ 0.05) were identified, including 128
with increased and 135 with decreased abundance. Principal
component analysis revealed a clear separation of the P1
and P7 mice metabolomic profiles (Figure 3A), a finding
supported also by the unsupervised hierarchical clustering
analysis (Figure S7). To gain insight into which biological
processes were most affected by the heart development, a heat
map of the global metabolomic profiling data set was sorted
by metabolite classification (differentially regulated metabolites,
DRM) among P1 and P7 stages. This map illustrates both the
direction and significance of change of metabolites among the
various pair-wise comparisons across the P1 and P7 hearts.
It can be noted that the glycogen metabolites maltotriose,
maltotetraose and maltopentaose, as well as the histamine
metabolites 1-methylimidazoleacetate and 4-imidazoleacetate
were highly abundant in P1 hearts (Figure 3B). The functional
linkage analysis of DEMs to KEGG pathways identified Glycogen
metabolism as well as Sphingolipid and Plasmalogen metabolism
as statistically enriched pathways (FE ≥ 2, E range10−5−10−2,
Figure 3C). The network depiction of these pathways with
corresponding DRM is illustrated in detail in Figures 3D,F.
The Glycogen metabolism and Plasmalogen functional modules
were significantly decreased (5 and 11 metabolites, including
8 DRM with significantly lowered abundance, respectively),
Frontiers in Physiology | www.frontiersin.org 7 April 2018 | Volume 9 | Article 365
Lalowski et al. Omics in Neonatal Mouse Heart
FIGURE 2 | Functional annotation network analysis encompassing differentially expressed proteins in the mouse heart. (A) Eighteen down-regulated DEP and twelve
up-regulated ones, including Rac1, Cdc42, and Gsk3b were functionally linked to Function of cardiovascular system, Rac and RhoA family GTPase and Cdc42
signaling, and Cardiac hypertrophy signaling. CP-canonical pathways. Log2FC-values of expression change are indicated, (B) Western Blot validation of differential
expression data. P1- 1 day, P7- 7 days. *p < 0.05, **p < 0.01, ***p < 0.001 (heteroscedastic 2-tailed t-test), n = 6, (C) Representative Ki-67 and MHC stained
samples of P1 and P7 myocardial tissues indicative of the amount of proliferative cardiomyocytes. n = 10 (P1) and n = 7 (P7), respectively. Mann-Whitney U-test,
***p < 0.001. 3262 (P1) and 2,747 (P7) cells / per group were counted.
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FIGURE 3 | Presentation of untargeted global profiling analyses of metabolomic data in the developing heart (P7/P1). (A) Principal component analysis of
metabolomic data demonstrating good separation and data grouping between measurement days. The percentage of variance is explained by the first and second
principal components (Comp.1 and Comp.2), shown in brackets. (B) Hierarchical clustering of differential metabolomic data with compound and data grouping;
asterisks denote metabolites with the highest fold change. Clustering by k-means including 50 clusters and leaf ordering, (C) Functional enrichment analysis of
differential metabolomic data ranked by the Fold Enrichment (FE), in yellow statistically enriched categories are highlighted, FE ≥ 2 (P7/P1). Network presentations of
the functional enrichments including (D) Glycogen metabolism, FE = 2.3, (E) Sphingolipid metabolism, FE = 2.0, and (F) Plasmalogen, FE = 2.1. The changes in
metabolites abundance and directions are indicated. Node border thickness is proportional to significance (p-values). n = 16, including four pools of four.
while Sphingolipid metabolism was significantly enriched in
P7 hearts (17 upregulated DRM encompassing sphingomyelin
metabolism). Plasmalogens and other phospholipids (Table S8)
were more abundant in P1 mice, pointing to an increased
cell membrane biosynthesis, which is required for proliferation.
These results also strengthen the view that P1 mice are
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relying on glycolytic metabolism with increased glycogen
storage.
Key Enzymes and Metabolites Involved in
Mitochondrial Oxidative Respiration Are
Elevated in the 7 Day Mouse Heart
Since the Mitochondrial dysfunction, Oxidative phosphorylation
and Synthesis of ROS functional categories were statistically
enriched in P7 hearts, we further mined the databases (see section
Materials and Methods and Mäkelä et al., 2016; Tikka et al.,
2016) to assign all mitochondrial proteins and distinguish DEP
of interest. Using this strategy, we assigned 99 mitochondria-
associated DEP (see scheme in Figure 4A and Table S1B).
It can be noted that several members of mitochondrial
chain complexes were altered in P7 hearts (Figure 4B), with
members of complex I, Ndufb6 (log2FC = 1.539) and Ndufb10
(log2FC = 1.229) showing the highest upregulation levels,
respectively. As the number and structure of mitochondria
in a cell is related to its activity, we subsequently examined
the morphological differences in heart mitochondria at the
P1 and P7 stage (Figure 4C). The mitochondrial volume
fraction and mitochondrial size were markedly larger in the
cardiomyocytes of P7 mice as compared to the P1 ones. The
number of mitochondrial cristae, indicating the mitochondrial
ability for energy production, was also significantly higher
in the P7 hearts. In accordance with their roles in the
electron transport chain, metabolomic studies showed an
increase in riboflavin metabolism (Figure 4D), with a significant
increase (values expressed as P7/P1) in both riboflavin and
flavin mononucleotide as well as flavin adenine dinucleotide.
Nicotinamide, nicotinamide N-oxide and 1-methylnicotinamide
in the nicotinamide metabolism pathway were also elevated.
Furthermore, thiamine, which serves as a co-factor for Krebs’
cycle enzymes, was found to be strongly upregulated together
with the levels of thiamine mono- and diphosphate. Finally,
respirometric measurements showed a consistent increase in
oxygen flux through the electron transport chain in P7 hearts
(Figure 4E). These results further support the switch to oxidative
phosphorylation at the P7 stage.
Comparative Proteomic and Metabolomic
Analysis of Elevated Fatty Acid β-Oxidation
in the 7 Day Mouse Heart
Under aerobic conditions the predominant substrates used by the
adult mammalian heart are free fatty acids, with long-chain fatty
acids being the major component. These fatty acids are coupled
to carnitines and transported into the mitochondrial matrix
by carnitine-O-palmitoyl-transferase (CPT) I. The acylcarnitines
are reconverted to fatty acyl-CoA by CPT II, located in the
inner membrane. Proteomic analysis revealed that both CPT
I and II were upregulated in P7 heart (Table S1A). Following
entry into the mitochondrion, fatty acids are converted to
units of acetyl-CoA through the process of fatty acid β-
oxidation (FAO). Querying the proteomic results against KEGG
pathways demonstrated an association of a total of 23 proteins
to the fatty acid degradation and among these the enzymes
Acaa2, Acsl1, Ecl1, Hadha, Hadhb, and Hsd17b10, linked
to FAO, were significantly upregulated in P7 mice hearts.
Differentially expressed enzymes assigned to Fatty acid β-
oxidation I pathway at P7 (KEGG annotation) are visualized in
Figure 5A. Consequently, the P7 heart was characterized by an
increased amount of metabolites involved in fatty acid synthesis
(Table S8), transport (medium and long-chain Acyl carnitines)
and FAO, such as Medium chain fatty acids (Figures 5B,C).
Selected, DRM are indicated in subnetworks in Figure 5C,
where sizes of nodes denote the level of statistical significance.
Consistent with an increase in oxidative phosphorylation, the P7
hearts are utilizing fatty acids as their energy substrate.
Proliferation Is Affected in Hypoxia
Conditions
Previous studies have demonstrated that inhibition of aerobic
respiration by systemic hypoxemia alleviates oxidative DNA
damage and reactivates the endogenous regenerative properties
of the adult mammalian heart (Nakada et al., 2017). We
utilized the hypoxic chamber to mimic fetal physiological
hypoxic conditions, and harvested the P1 hearts, from which the
cardiomyocytes were isolated. Exposure to low oxygen (3% O2)
for 24 h resulted in an increased proliferation of cardiomyocytes
as judged by immunodetection with Ki-67 and MHC (3.4%
vs. 1.9%, p < 0.05; Figure 6A). These findings support the
notion that targeting hypoxia signaling may represent a novel
therapeutic strategy for cardiac regeneration.
Fructose Metabolism and
Fructose-Induced Glycolysis Are Enhanced
in the P1 Hearts
Previous study by Park et al. (2017) provided compelling
evidence that the unique anoxia resistance of the naked mole-
rats is strongly dependent on metabolic rewiring under oxygen
deprivation, and in particular, induction of fructose-induced
glycolysis. Data from metabolomics experiments revealed
marked upregulation of fructose metabolism in P1 hearts
(Figures 6B,C). Therefore, we reasoned that metabolic rewiring
toward fructose-induced glycolysis could explain, at least in
part, enhanced cardiomyocyte proliferation and endogenous
regenerative capacity of the neonatal mice (Figure 6D). In
P1 hearts, the mRNA expression of 6-phosphofructo-2-
kinase/fructose-2.6-bisphosphatase 2 (Pfkfb2), an activator of
phosphofructokinase 1 (Pfk1) and a rate-limiting enzyme of
cardiomyocyte glycolysis, was 3- to 4-fold increased as compared
to P7 hearts (Figure 6E). Furthermore, the mRNA expression
of the key fructose-metabolizing enzyme ketohexokinase-C
(Khk-c), the isomer displaying superior affinity for fructose as
compared to Khk-a, was also increased by 2- to 3-fold in P1
hearts (Figure 6E). Finally, the mRNA expression of hypoxia-
inducible lactate transporter Mct4, responsible for proton
symport-mediated lactate eﬄux (Jones and Morris, 2016), was
increased more than 4-fold in P1 hearts (Figure 6E). In line
with these findings, transcriptomic analyses revealed a strong
association of HIF1α signaling to a number of DEG (24 DEG,
Table S7). HIF1α activation of SF3B1-dependent splicing of
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FIGURE 4 | Mitochondrial sorting of proteomic and metabolomic data in the developing heart. (A) Scheme of mitochondrial assignment of proteomic data with
bioinformatics filtering steps; IMPI—the mitochondrial proteome database, (B) Portrayal of mitochondrial chain complexes (I–V) with assigned, differentially expressed
(Continued)
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FIGURE 4 | proteins, (C) Electron microscopy depiction of heart mitochondrial morphology at P1 and P7 stage. Although the number of mitochondria is relatively
unchanged (P7 vs. P1), the size, mitochondrial volume and the number of cristae increase over time. **p < 0.01, ***p < 0.001 by Mann-Whitney-test, (D) Network
presentations of the mitochondrial metabolites with underlying processes indicated. The changes in metabolites abundance are indicated. In red-upregulation, in
green-downregulation. Size of the node corresponds to an increasing significance (p-values), (E) Oxygen flux measurements with Oroboros. L, resting state; CI cyt,
complex I after addition of cytochrome C; CI+II, after activation of complex II with succinate; ETS, electron transfer system, Complex II (after inhibition of complex I by
rotenone). n = 6, *p < 0.05, Mann-Whitney U-test.
KHK enforces fructolysis to promote cardiac hypertrophy in
response to pathologic stress (Mirtschink et al., 2015). Taken
together, these data reveal enhanced fructose-driven metabolism
and fructose-induced glycolysis as the key metabolic pathways
in the neonatal mouse heart. These differences may also help
explain the intriguing endogenous regenerative capacity of the
neonatal mice heart.
Changes in the Amino Acid Metabolism
Underlie the Transition and Differences in
Energy Utilization
In subsequent steps, we searched for specific regulators of the
regenerative capacity and turned our attention to amino acids
whose metabolism in the neonatal heart has not been studied
previously. Changes in amino acids between P1 and P7 stages are
plotted in Figure 7 and listed in detail in the Table S8.
Overall, amino acids allocated to the Methionine, cysteine,
SAM and taurine metabolism, Creatine and Glutathione
metabolism were significantly enriched in P7 hearts, whereas
amino acids belonging to the Histidine metabolism, Leucine,
isoleucine and valine metabolism, the Glycine, serine and
threonine metabolism and the Urea cycle encompassed many
members with prominently lowered abundance. Selected
metabolites from sub-networks and the normalized intensities
are shown as insets. In summary, we pinpointed 12 various
functional amino acid network modules comprising various
DRM with altered abundance.
DISCUSSION
Current treatments for patients suffering a myocardial infarction
are only palliative and the loss of massive amounts of
cardiomyocytes in the injured heart, accompanied by fibrotic scar
formation, increases the risk of heart failure and cardiovascular
mortality. The development of novel strategies to enhance
endogenous tissue regeneration and repair after MI is thus
required. The neonatal mouse heart at P1 has an exceptional,
inherent capacity to regenerate after a myocardial infarction, a
capacity lost by 7 days of age (P7). The neonatal heart represents
an important model to elucidate the mechanisms behind the
heart’s regenerative switch (Porrello et al., 2011; Haubner et al.,
2012). Better understanding of physiological development in
the postnatal period of the mouse heart, specifically the shift
from hyperplasia to hypertrophy, as well as of the metabolic
changes in energy demand, may contribute to successful
future elucidation on how to activate regenerative molecular
mechanisms in adult mammalian hearts. Moreover, revealing
such mechanisms may provide targets for local stimulation or
reactivation of cardiomyocyte proliferation in adult tissue (Foglia
and Poss, 2016). Since the combined use of proteomics together
with metabolomics and transcriptomics permits a holistic view
to a biological system, we sought to explore the postnatal
development using these techniques to understand the intrinsic
repair mechanism. Moreover, to our knowledge, this is the
first study combining in-depth proteomic, metabolomic and
transcriptomic analyses in the neonatal heart model.
Several in-depth proteomic investigations have been targeted
at generating detailed inventories of diverse mouse tissues,
including heart, using a multitude of different analysis strategies
(reviewed in Kislinger and Gramolini, 2010). Decreased
proteolytic capacity and accruing proteotoxicity have been
suggested to directly exacerbate outcomes in heart failure,
cardiac infarcts and hypertrophy (Wang and Robbins, 2006; Li
et al., 2011). We have compared the results of relative protein
abundance analyses at P1 and P7 stage with the results of a
large dataset (performed with the usage multi-step subcellular
purifications and various enrichment techniques) of protein
turnover dynamics in the heart of six common genetic strains
of adult mice (however not including the strain used in our
study), acquired under both normal and hypertrophic conditions
(Lau et al., 2016). The majority of our proteomic data was
retained in a data set provided by Lau et al., with 1,817 common
proteins (Figure S8). Similarly, we related our proteomics
data to a peptidomics data set from neonatal mouse heart at
the same stages (Fan et al., 2017). Three out of four cardiac-
related precursor proteins, corresponding to differentially
expressed peptides, whose expression was validated by the
authors by quantitative PCR at the mRNA level displayed the
same trends of change in their expression (Myh7, Hadha and
Hspb1; Table S1), while one, Cox8b was not found in our
dataset (one differentially expressed peptide found by Fan et al.,
2017). The database searches linked 30 DEP to cardiovascular
functions at P7 (Table S5 and Figures 2A,B). Among these
were members of Rho/Rac/Cdc42 signaling cascades, molecular
switches implicated in cytoskeletal dynamics, cell movement
and polarity, differentiation, contraction and motility and other
common cellular functions, important for spatiotemporal fine
tuning of numerous cardiovascular functions and cardiovascular
development (Loirand et al., 2013). Our data support the
neonatal heart transition from hyperplastic to hypertrophic
growth (Figure 2C), which is consistent with the reported
correlation between the proliferative capacity of cardiomyocytes
and their regenerative potential (Jopling et al., 2010; Haubner
et al., 2012; Porrello et al., 2013; Senyo et al., 2013). Moreover,
KEGG/Reactome functional association identified processes
related to hypertrophy (Figure 1A) as statistically significant
and associated with differential expression changes at P7.
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FIGURE 5 | Comparative analysis of differentially expressed proteomic and differentially regulated metabolomic data. (A) Differentially expressed upregulated enzymes
assigned to Fatty acid-β-oxidation pathway at 7 days (KEGG annotation), as indicated, (B) The same pathway was pinpointed with altered differential regulations of
various metabolites, encompassing specifically Fatty acid metabolism (Acyl carnitine) and Medium Chain fatty acid functional modules. (C) The differentially regulated
metabolites are indicated in subnetworks shown in rectangles on the right.
During the first week of the neonatal heart development, a
significant loss of Ki-67 positive, proliferating cardiomyocytes
was seen. We also annotated other signaling pathways that
may be important regulators of the regenerative potential of
the neonatal heart. IPA canonical pathway analysis predicted
upregulated activity of mTOR, eIF4 and Thrombin signaling in
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FIGURE 6 | Proliferation of cardiomyocytes and fructolytic pathway are strongly affected in P7 hearts. (A) Hypoxia condition (3% O2) increases the cardiomyocyte
proliferation rate. The cardiomyocytes were isolated from P1 hearts and kept in hypoxia chamber for 24 h. The number of proliferative cardiomyocytes stained by
(Continued)
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FIGURE 6 | Ki-67 and MHC was counted. n = 10, respectively. Mann-Whitney U-test, *p < 0.05. 3407 (normoxia) and 3,072 (hypoxia) cells / per group were
counted, (B) The network overview of sugar metabolism with two functional modules depicting Fructose, mannose and galactose metabolism and Glycolysis,
gluconeogenesis and Pyruvate metabolism. The downregulation of fructose in P7 hearts was observed in metabolomics experiments, marked by rectangular, (C) The
representation of a fructose downregulation in P7 hearts. Box and whiskers plot, the median, lower 25% and upper 75% percentiles and minimum and maximum
values are shown. Welch’s Two-Sample t-test, **p < 0.01, *p < 0.05. Glucose levels are shown in comparison, (D) The overview of the fructolysis/glycolysis pathways
with affected targets. The downregulated metabolites (Fructose, Fru; dihydroxyaceton phosphate, DHAP), enzymes (Phosphofructokinase-2, Pfkfb2; ketohexokinase
isoform c, Khk-c; Aldolase a/c, Aldoa/c measured in MSE experiments) and transporters (Glut1/Slc2a1; Mct4/Slc16a3) are indicated with an arrow. Lac, lactate;
Pyruvate (Pyr), Mct4, monocarboxylate transporter, LDH, lactate dehydrogenase, (E) The downregulation of Glut1, Mct4, Khk-c and Pfkfb2 at the mRNA level was
assessed by q-PCR, by comparing the RNA abundance from tissue samples derived from P1 and P7 hearts. Ct values were normalized to the level of a
housekeeping gene 18S in each measurement, n = 10. Mann-Whitney U-test, ***p < 0.001.
P1 mice, as well as increased PI3K/AKT signaling (Table S3),
all of which are associated with increased cell proliferation
(Ma and Blenis, 2009) and cell-cycle regulation (Figure 1C)
(Laplante and Sabatini, 2009; Vivien et al., 2016). In addition,
mTOR signaling is also a key regulator of cell metabolism
(Laplante and Sabatini, 2009). Metabolomic amino acid
analysis identified some additional, putative regulators of the
proliferative response. High abundance of histidine, histamine
and histamine metabolites was observed in P1. Histamine can
serve as an autocrine growth factor in cancer, stimulating cell
proliferation (Rivera et al., 2000). Furthermore, an increase in S-
adenosylmethionine conversion to S-adenosylhomocysteine was
observed (Figure 7). S-adenosylhomocysteine plays a significant
role in regulating nucleotide and protein expression through
methylation and is important for cell function and survival by
altering cell-cycle kinetics to arrest cell growth (Boal et al., 2011).
These pathways represent previously unreported, potentially
interesting targets for local pharmacological activation of
cardiomyocyte proliferation in heart regeneration.
During the neonatal period there is a shift in the energy
utilization from proliferating cardiomyocytes depending on
glycolysis in P1 hearts to cardiomyocytes relying on oxidative
phosphorylation in P7 hearts, which similarly to the adult
ones utilize fatty acids as its primary fuel source under most
conditions (Lopaschuk and Jaswal, 2010). Taking a closer look
at molecules involved in energy metabolism, we found that the
majority of enzymes assigned to fatty acid β-oxidation (FAO)
and Krebs cycle were upregulated in P7 hearts, whereas glycolytic
enzymes were downregulated. Our findings corroborated the
results by Puente et al. (2014) and showed that ∼80% of
enzymes detected in both studies display the same direction
in their expression. Furthermore, our metabolomic profiling
revealed that the P7 hearts exhibited a significant increase in
the majority of medium chain fatty acids and acylcarnitines,
the metabolites which are formed in order for long-chain fatty
acids to be transported from cytosol to the mitochondrial
matrix for FAO. These results are, therefore, consistent with
significant changes in fatty acid transport and β-oxidation rates
in P7 hearts, further reinforced by the upregulation of multiple
enzymes involved in FAO, measured in HDMSE proteomic
experiments (Figure 5 and Table S1). Interestingly, in a recent
study in which adult mice were subjected to normoxic or hypoxic
conditions post MI, hypoxia induced metabolic reprogramming
of adult cardiomyocytes, resulting in cell-cycle re-entry and
myocardial regeneration (Nakada et al., 2017). Multiple-omics
analyses of these hearts showed striking similarity to our data,
with hypoxic animal and our neonatal P1-omics data having
similar directionality in their trends (Nakada et al., 2017),
indicative of feasibility in reversal of glycolytic energy utilization
in adult hearts. We also demonstrated that the shift to oxidative
phosphorylation is accompanied by morphological differences
in mice heart mitochondria and an increased number of cristae
in P7 mouse hearts (Figure 4C) similarly as presented in Puente
et al. (2014). Moreover, while the number of mitochondria did
not significantly increase from P1 to P7 stage, bothmitochondrial
size and volume fraction were markedly increased in P7 mice
hearts. Interestingly, our metabolomic analyses demonstrated
significant increases in nicotinamide (NAM) and riboflavin
metabolism in P7 hearts (Figure 4D). NAM is a precursor of
nicotinamide adenine dinucleotide, which together with FADH2
serve as electron carriers in oxidative phosphorylation and
cofactors for many dehydrogenases. NAM N-oxide (increased in
P7) is a natural metabolite of NAM with no assigned biological
function. High doses of NAM N-oxide have been reported to
affect the differentiation of leukemia cells (Iwata et al., 2003),
and metabolites of NAM clearance were proposed as potential
biomarkers of peroxisome proliferator-activated receptor-α
(PPAR) activation, having a key role in fatty acid β-oxidation
(Zhen et al., 2007). Thiamine metabolism was also significantly
upregulated (Figure 4D). Thiamine is a co-factor of Krebs cycle
enzymes, such as pyruvate dehydrogenase and α-ketoglutarate
dehydrogenase, important for regulating the flux of metabolites
through the cycle. In addition, some amino acids feeding this
cycle, such as tyrosine, asparagine, methionine, and glutamine
were found at significantly higher levels in P7. Altogether
these findings, in combination with multiple mitochondrial
enzymes of the electron transport chain being significantly
upregulated (Figures 4A,B), bioinformatic associations to
oxidative phosphorylation (Figures 1A–C) and oxygen flux
increase in the P7 hearts (Figure 4E), corroborated the shift
to oxidative phosphorylation in P7 mouse hearts. In contrast,
several enzymes and metabolites in carbohydrate utilization such
as glucose and glucose-derived metabolites were abundant in
P1 hearts (Table S8). Specifically, P1 hearts contained higher
levels of glycolytic intermediates and glucogenic amino acid
metabolites (Figure 7 and Table S8). In line with this, proteomic
measurements showed higher abundance (at P1) of the glycolytic
enzymes pyruvate kinase (Pklr), phosphoglycerate kinase 2
(Pgk2) and α-enolase (Eno2) (Table S1A). Correspondingly,
glycogen metabolism was significantly upregulated in P1 hearts.
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FIGURE 7 | Amino acid network presentations of global metabolomic analysis of the developing heart (P7/P1). Pathways with differentially regulated metabolites are
indicated. Insets indicate the normalized intensities of individual amino acids (numbered) in selected metabolic pathways; P1 (red) and P7 (blue). n = 16, including four
pools of four hearts. Node border thickness is proportional to significance (p-values).
These results support the view similar to cancer cells; glycolytic
energy utilization is a key driver behind the proliferative capacity.
The metabolic reprogramming to oxidative phosphorylation and
associated molecular mechanisms might, therefore, be critical
for loss of the regenerative potential.
The naked mole-rat survives anoxia by substituting fructose
for glucose as the energy substrate for anaerobic metabolism in
the heart and brain (Park et al., 2017). Such a switch to fructose-
driven glycolytic respiration avoids feedback inhibition of
glycolysis via phosphofructokinase (Park et al., 2017). We report
here that fructose metabolism and fructose-induced glycolysis
are enhanced in neonatal mice heart under normoxic conditions.
Our results also suggest that neonatal mice heart utilizes
proton symport-mediated lactate eﬄux to avoid intracellular
lactate accumulation and alterations in intracellular pH level.
Previously, Mirtschink et al. have demonstrated that myocardial
hypoxia activates fructose metabolism via HIF-1α-SF3B1-KHK-
C axis in human and mice models of pathological cardiac
hypertrophy (Mirtschink et al., 2015) underlying the importance
of fructose metabolism in the regulation of cardiomyocyte
growth in adults. Interestingly, MCT4 expression is induced
by hypoxia (Mirtschink et al., 2015) and upregulated in many
proliferating cancer cells (Jones and Morris, 2016), whereas
MCT4 inhibition has been shown to prevent hypoxic response,
cell proliferation and tumor progression (Voss et al., 2017).When
isolated cardiac myocytes from P1 neonatal mice were cultured
under normoxia or under mimicked physiological hypoxia, a
clear upsurge in cell proliferation in hypoxic condition was
evident (Figure 6A). These results suggest the presence of a
functional link between the observed fructose-induced glycolysis
active at P1 and cardiomyocyte proliferation, an observation
which warrants further in-depth exploration. Taken together,
our results underline the key importance for cell metabolism
in regulation of cardiomyocyte proliferation and innate cardiac
regenerative capacity.
Although the majority of adult heart cardiomyocytes are
terminally differentiated, cardiomyocytes may be capable, to
a limited degree, of self-renewal in order to repair the daily
micro-damages that occur in the adult heart. It has been shown
that human cardiomyocytes have an approximate turnover rate
of 1% per year, which declines further after the age of 50
(Bergmann et al., 2015). In neonatal mice, proliferation of
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existing cardiomyocytes is the primary mechanism behind the
regenerative potential (Jopling et al., 2010; Haubner et al., 2012;
Porrello et al., 2013). Although this native capacity is insufficient
to compensate for large-scale tissue damage associated with MI,
it is important to clarify the mechanisms that could trigger adult
cardiomyocytes to de-differentiate, re-enter the cell-cycle and
proliferate, in order to replace damaged cardiomyocytes after
a MI (Porrello and Olson, 2014). An increase in the synthesis
of ROS accompanies the shift to oxidative phosphorylation in
the oxygen-rich postnatal environment, and postnatal increase
in ROS formation induces cell-cycle arrest through activation
of the DNA damage response (Puente et al., 2014). Likewise,
the transcriptomic analysis revealed a massive change in the
mitotic machinery in the postnatal heart, correlating very closely
with shutting down of the cell-cycle (Haubner et al., 2012).
Scavenging of ROS in cardiomyocytes or inhibiting the DNA
damage response pathway delayed postnatal cell-cycle arrest
of cardiomyocytes (Puente et al., 2014). Adult mice which
suffered a MI and were exposed to hypoxia, showed significantly
decreased ROS formation and improved heart regeneration
(Nakada et al., 2017). ROS, therefore, have been proposed as
important mediators in the shift from proliferating growth to
terminally differentiated cells, which grow by hypertrophy in the
postnatal mammalian heart (Puente et al., 2014; Nakada et al.,
2017). Alike, we also demonstrated that multiple elements related
to oxidative stress were upregulated in P7 hearts. IPA functional
annotations recognized significant upregulation of Synthesis and
Metabolism of reactive oxygen species (Figure 1C, Figure S3 and
Table S7). Moreover, metabolomic profiling, identified novel
regulators of oxidative stress, previously not linked to this setup.
Increase of oxidative stress markers such as opthalmate, several
gamma-glutamyl amino acids, 5-oxoproline, 2-hydroxybutyrate,
and methionine sulfoxide (Figure 7), as well as a robust rise
in lipid peroxidation mediators such as 4-hydroxy-2-nonenal
(HNE) and 13-HODE and 9-HODE (Table S8) were observed
in P7 hearts. Similarly, eicosanoids were highly abundant
in P7. Label free HDMSE quantitation revealed significant
downregulation of the mitochondrial isoform of aldehyde
dehydrogenase (ALDH2) in P7 hearts, which plays an important
role in neutralizing HNE produced by ROS-induced lipid
peroxidation (Table S1). Increased HNE accumulation can lead
to myocardial dysfunction and heart failure, and modify essential
cardiac survival signaling molecules (Mali and Palaniyandi,
2014). On the other hand, molecules with antioxidant properties
such as N-acetylmethionine and taurine were elevated at
P7 (Figure 7), likely in a cellular attempt to neutralize the
generated ROS. This implies that the P7 hearts are characterized
by an increase of oxidative stress likely counteracted by
physiological antioxidants. Metabolomic analyses in P1 also
revealed significant upregulation of plasmalogen metabolism
(Figures 3E,F). Plasmalogens together with other phospholipids
are major constituents of the cell membrane, and high abundance
of phospholipids in P1 mice points to an increased cell
membrane formation, consistent with an increased propensity
for cell proliferation. Plasmalogens may have a protective role
in P1 mice hearts since they have been shown to protect
against ROS-induced lipid peroxidation. Furthermore, low levels
of plasmalogens are associated with increased cardiovascular
mortality (Zoeller et al., 1988; Stenvinkel et al., 2004), and
sphingolipid metabolism is upregulated in P7 hearts under
oxidative stress (Nikolova-Karakashian and Reid, 2011; de
Faria Poloni et al., 2014). An upsurge in ceramide levels can
activate nicotinamide adenine dinucleotide phosphate (NADPH)
oxidase, which in turn aggregates to lipid rafts and together with
Src and Rac1 forms functional redox signaling platforms. This, in
consequence, activates ROS, increases hypertrophy, cytoskeletal
remodeling and inflammation (Nikolova-Karakashian and Reid,
2011; de Faria Poloni et al., 2014). Increased NADPH oxidase
activity has been revealed in P7 hearts, while its’ activity was
markedly decreased in adult mouse hearts subjected to hypoxia
(Puente et al., 2014; Nakada et al., 2017). Furthermore, increases
in NADPH oxidase activity can be functionally coupled to the
Rho family GTP-ases: RhoA, Rac1 and Cdc42 (upregulated in
P7, as measured in both transcriptomic and proteomics analyses;
Figure 2 and Figure S6), which actively regulate actin cytoskeletal
changes, thereby creating a putative link between oxidative stress
and hypertrophic growth in the neonatal heart (Brown et al.,
2006; Satoh et al., 2006).
Altogether, using systems biology approaches we havemapped
fundamental differences in energy utilization of the neonatal
mouse heart during the first week of life and demonstrated
that a transition from fructose-induced glycolysis under hypoxic
conditions to oxidative phosphorylation, with a concomitant
increase in physiological oxidative stress points to a switch
from hyperplastic to hypertrophic growth. Furthermore, we
pinpointed fructolysis, mTOR, plasmalogen, methionine and
histidine metabolism, lipid peroxidation and sphingolipid
signaling as novel pathways involved in these processes, suitable
for pharmacological interventions (cartoon in Figure 8). We
believe that the in-depth characterization of molecular processes
taking place during the early postnatal days, a time period
shown in strong correlation with literature to be specifically
FIGURE 8 | Schematic representation of proposed regulatory events detected
in the study, taking place during P1–P7 neonatal heart development. The
processes described in detail (in Results and Discussion sections) are
summarized in the cartoon. SAM, S-adenosylmethionine; SAH,
S-adenosylhomocysteine.
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associated with loss of cardiac regenerative potential upon injury,
will facilitate more targeted research on heart regeneration and
paves way toward generation of new hypotheses when designing
cardiac therapies.
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